Athol U Wells Selected Research

cyclopropapyrroloindole

11/2017	Evaluation of visual and computer-based CT analysis for the identification of functional patterns of obstruction and restriction in hypersensitivity pneumonitis.
9/2017	Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices.
5/2017	Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis.
9/2016	Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function.
2/2014	An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.
4/2007	Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent.
4/2003	Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Athol U Wells Research Topics

Disease

49	Idiopathic Pulmonary Fibrosis 01/2022 - 04/2003
38	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 10/2003
20	Disease Progression 01/2022 - 04/2013
20	Fibrosis (Cirrhosis) 01/2022 - 05/2003
18	Bronchiectasis 01/2022 - 08/2003
17	Sarcoidosis (Schaumann Disease) 01/2022 - 04/2002
16	Pulmonary Hypertension 03/2022 - 06/2007
15	Lung Diseases (Lung Disease) 01/2020 - 09/2005
14	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 04/2003
14	Emphysema 01/2021 - 04/2003
9	Systemic Scleroderma (Systemic Sclerosis) 12/2021 - 04/2013
7	Dyspnea (Shortness of Breath) 11/2018 - 02/2004
6	Idiopathic Interstitial Pneumonias 01/2021 - 07/2014
5	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2021 - 08/2012
4	Pulmonary Sarcoidosis 11/2020 - 01/2011
4	Pneumonia (Pneumonitis) 01/2019 - 11/2009
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2017 - 03/2008
4	Infections 04/2014 - 05/2003
3	Death (Near-Death Experience) 10/2013 - 04/2012
2	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2018 - 01/2017
2	Cough 01/2017 - 09/2013
2	Lung Injury 05/2016 - 01/2011
2	Pain (Aches) 10/2013 - 01/2006
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2013 - 07/2009
2	Fatigue 10/2013 - 09/2013
2	Neoplasms (Cancer) 08/2013 - 01/2006
2	Inflammation (Inflammations) 04/2008 - 03/2006
2	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2006 - 06/2002
2	Bronchiolitis 10/2003 - 06/2002
1	Sclerosis 01/2022
1	Lymphocytosis 01/2022
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2021
1	COVID-19 01/2020
1	Diarrhea 10/2019
1	Hypoxia (Hypoxemia) 10/2018
1	Rheumatoid Arthritis 12/2017
1	Dermatomyositis (Dermatopolymyositis) 01/2017

Drug/Important Bio-Agent (IBA)

18	Carbon MonoxideIBA 12/2021 - 02/2004
14	nintedanibIBA 01/2022 - 09/2014
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2009
11	pirfenidoneIBA 02/2021 - 09/2014
7	Oxygen (Dioxygen)IBA 01/2020 - 05/2003
7	cyclopropapyrroloindoleIBA 11/2017 - 04/2003
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2015
5	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2017 - 05/2003
5	Rituximab (Mabthera)FDA Link 01/2017 - 09/2012
4	Sildenafil Citrate (Viagra)FDA Link 01/2021 - 11/2010
4	CytokinesIBA 01/2017 - 03/2003
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016 - 12/2006
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2009
3	Indicators and Reagents (Reagents)IBA 01/2017 - 12/2008
3	AutoantibodiesIBA 11/2016 - 12/2006
3	CC ChemokinesIBA 12/2015 - 11/2003
3	ambrisentan FDA Link 11/2015 - 05/2013
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2013 - 04/2008
2	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2022 - 01/2022
2	riociguatIBA 01/2021 - 01/2019
2	simtuzumabIBA 01/2020 - 01/2017
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2019 - 08/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 12/2006
2	CollagenIBA 01/2017 - 06/2015
2	ProstaglandinsIBA 04/2016 - 01/2013
2	MucinsIBA 02/2016 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2013
2	Antifibrotic AgentsIBA 01/2016 - 04/2014
2	InterferonsIBA 09/2013 - 08/2013
2	Prednisolone (Predate)FDA LinkGeneric 09/2013 - 12/2006
2	OligonucleotidesIBA 08/2013 - 11/2004
2	Interleukin-6 (Interleukin 6)IBA 04/2013 - 03/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2008 - 11/2004
2	NucleotidesIBA 11/2003 - 04/2002
1	Keratins (Keratin)IBA 01/2022
1	DEAE-Dextran (Pulsar)IBA 01/2022
1	antigen CYFRA21.1IBA 01/2022
1	AbituzumabIBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	SteroidsIBA 01/2021
1	AntigensIBA 01/2021
1	pamrevlumabIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2018
1	Protein-Arginine DeiminasesIBA 12/2017
1	Blood Proteins (Serum Proteins)IBA 12/2017
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017
1	AntacidsIBA 01/2017

Therapy/Procedure

30	Therapeutics 03/2022 - 02/2007
16	Traction 01/2022 - 08/2003
6	Palliative Care (Palliative Therapy) 01/2018 - 04/2012
3	Immunomodulation 12/2018 - 04/2013
2	Drug Therapy (Chemotherapy) 04/2022 - 01/2013
2	Lung Transplantation 01/2022 - 01/2011
2	Cardiac Catheters 07/2014 - 01/2011
1	Radiotherapy 04/2022
1	Precision Medicine 02/2022
1	Contraindications 01/2018